Adiponectin and the vasoactive intestinal peptide receptor both have antiinflammatory signaling properties that are correlated with less severe RA and with the amelioration of collagen-induced arthritis in mice (42–46). This evidence concerns the gene ADIPOQ and rheumatoid arthritis.